Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Retained Earnings of -$1.7 billion for Q1 2026, down 2.0% YoY from -$1.8 billion in Q1 2025, and down 0.62% sequentially from -$1.7 billion in Q4 2025.

Amarin Corp Plcuk (AMRN) Retained Earnings (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Retained Earnings across 17 years of filings, most recently posting -$1.7 billion for Q1 2026.

  • In Q1 2026, Retained Earnings fell 2.0% year-over-year to -$1.7 billion; the TTM figure through Mar 2026 stood at -$1.7 billion (down 2.0% YoY), while the FY2025 annual figure was -$1.7 billion, down 2.33% from the prior year.
  • Retained Earnings slipped to -$1.7 billion in Q1 2026, from -$1.7 billion in the prior quarter.
  • Over the last five years, Retained Earnings for AMRN reached as high as -$1.5 billion in Q1 2022 and fell as low as -$1.7 billion in Q1 2026.
  • The 5-year median for Retained Earnings is -$1.6 billion (2024), against an average of -$1.6 billion.
  • The widest YoY moves for Retained Earnings: up 1.55% in 2022, down 7.44% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$1.5 billion in 2022, then decreased by 3.87% to -$1.6 billion in 2023, then slipped by 5.18% to -$1.7 billion in 2024, then dropped by 2.33% to -$1.7 billion in 2025, then retreated by 0.62% to -$1.7 billion in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$1.7 billion, -$1.7 billion, and -$1.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 29.51 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -14.83 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -17.87 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 9.67 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 66.72 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -190.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 78.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -7.20 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -1.72 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.72 Bn
Dec 31, 2025 -1.71 Bn
Sep 30, 2025 -1.71 Bn
Jun 30, 2025 -1.70 Bn
Mar 31, 2025 -1.68 Bn
Dec 31, 2024 -1.67 Bn
Sep 30, 2024 -1.62 Bn
Jun 30, 2024 -1.59 Bn
Mar 31, 2024 -1.60 Bn
Dec 31, 2023 -1.59 Bn
Sep 30, 2023 -1.58 Bn
Jun 30, 2023 -1.56 Bn
Mar 31, 2023 -1.54 Bn
Dec 31, 2022 -1.53 Bn
Sep 30, 2022 -1.53 Bn
Jun 30, 2022 -1.52 Bn
Mar 31, 2022 -1.45 Bn
Dec 31, 2021 -1.42 Bn
Sep 30, 2021 -1.44 Bn
Jun 30, 2021 -1.42 Bn